Tarsus Pharmaceuticals
The Director, Translational Science/Pharmacokinetics shapes the scientific and strategic direction of pharmacokinetics, drug metabolism, bioanalysis, and translational PK/PD across the company's portfolio. This role involves designing PK strategies for various development stages, leading internal and external activities, and partnering with cross-functional teams to guide candidate selection and regulatory submissions. The position requires translating complex scientific data into actionable recommendations to drive program progress and patient outcomes.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
Right around the average for this role